| Literature DB >> 34245863 |
Real Sumayya Abdul Sattar1, Mamta P Sumi1, Arun Kumar1, Abhay Kumar Sharma1, Ejaj Ahmad1, Asgar Ali2, Bhawna Mahajan3, Sundeep Singh Saluja4.
Abstract
Sphingosine-1-Phosphate (S1P) plays an important role in normal physiology, inflammation, initiation and progression of cancer. Deregulation of S1P signaling causes aberrant proliferation, affects survival, leads to angiogenesis and metastasis. Sphingolipid rheostat is crucial for cellular homeostasis. Discrepancy in sphingolipid metabolism is linked to cancer and drug insensitivity. Owing to these diverse functions and being a potent mediator of tumor growth, S1P signaling might be a suitable candidate for anti-tumor therapy or combination therapy. In this review, with a focus on colorectal cancer we have summarized the interacting partners of S1P signaling pathway, its therapeutic approaches along with the contribution of S1P signaling to various cancer hallmarks.Entities:
Keywords: CRC; Cancer hallmarks; Deregulation; S1P signaling; Therapy
Mesh:
Substances:
Year: 2021 PMID: 34245863 DOI: 10.1016/j.cellsig.2021.110080
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315